Geert J.C.M. Kolvenbag

Film Independent — United States

Medicine · Health Sciences

20h-index2.0kcitations40works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(30), Hormonal and reproductive studies(17), Prostate Cancer Diagnosis and Treatment(14), Estrogen and related hormone effects(9), Radiopharmaceutical Chemistry and Applications(7)

Publications40 total

Consistent Race Performance in Racing Pigeons: A Case Report Confirming a Favorable Genetic Profile
2024Open Access
The Impact of Gender in Young Bird Pigeon Racing
2022· 1 citedOpen Access
Cover Image
Veterinary Medicine and Science·2021Open Access
A phase 2 study to assess olaparib by homologous recombination deficiency status in patients with platinum-sensitive, relapsed, ovarian, fallopian tube, or primary peritoneal cancer.
Journal of Clinical Oncology·2017· 3 cited
Nonsteroidal Antiandrogens
Humana Press eBooks·2009· 2 cited
Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer: First Analysis of the Early Prostate Cancer Program
The Journal of Urology·2002· 229 cited
Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer:
The Journal of Urology·2002· 4 cited
Antiandrogen monotherapy: a new form of treatment for patients with prostate cancer
Urology·2001· 66 cited
Androgen antagonists: Potential role in prostate cancer prevention
Urology·2001· 22 cited
The Prostate Cancer Continuum: The Role of Bicalutamide (Casodex<sup>®</sup>)
The Prostate Journal·2001· 2 cited
Bicalutamide and Flutamide, Each in Combination with Luteinizing Hormone‐Releasing Hormone Analogs, in Advanced Prostate Cancer: Exploratory Analysis of Impact of Extent of Disease by Bone Scan on Outcome
The Prostate Journal·2000· 10 cited
Does prolonged combined androgen blockade have survival benefits over short-term combined androgen blockade therapy?
Urology·2000· 19 cited
Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues
The Prostate·1999· 22 cited
Bicalutamide dosages used in the treatment of prostate cancer
The Prostate·1999· 56 cited
Antiadrogens in prostate cancer
Data Archiving and Networked Services (DANS)·1999
Comparison of goserelin and leuprolide in combined androgen blockade therapy
Urology·1998· 42 cited
Bicalutamide for Advanced Prostate Cancer: The Natural Versus Treated History of Disease
The Journal of Urology·1998· 3 cited
HIGH DOSE BICALUTAMIDE FOR ANDROGEN INDEPENDENT PROSTATE CANCER: EFFECT OF PRIOR HORMONAL THERAPY
The Journal of Urology·1998· 206 cited
Bicalutamide (Casodex®) in the treatment of prostate cancer: History of clinical development
The Prostate·1998· 91 citedOpen Access
Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: Final report of a double-blind, randomized, multicenter trial
Urology·1997· 148 cited
page 1 of 2Next →

Frequent Co-authors

Paul F. Schellhammer(12), Peter Venner(10), Anthony L. Patterson(10), Mark S. Soloway(9), Norman L. Block(8), Michael F. Sarosdy(8), Nicholas J. Vogelzang(8), Roohollah Sharifi(5), David G. McLeod(4), Peter Iversen(3), Gerald W. Chodak(3), Kevin Carroll(3), Julie Jones Schellenger(3), Eric A. Klein(3), Yusong Chen(3), G. Blackledge(3), Howard I. Scher(2), Christine Liebertz(2), William Kevin Kelly(2), Madhu Mazumdar(2)